Synchrony Financial director awarded 660 restricted stock units
Synchrony Financial reported an equity award to one of its directors.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Synchrony Financial reported an equity award to one of its directors. On December 31, 2025, the director acquired 660 shares of Synchrony Financial common stock in the form of restricted stock units at a reference price of $83.43 per share. After this transaction, the director beneficially owns 3,972 shares of common stock directly.
The 660 restricted stock units will vest in full on December 31, 2026, and each unit represents a contingent right to receive one share of Synchrony Financial common stock. This filing reflects a routine director equity grant rather than an open-market stock purchase or sale.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 660 | $83.43 | $55K |
Footnotes (1)
- F1. Represents restricted stock units that will vest in full on December 31, 2026. Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Synchrony Financial (SYF) report in this filing?
A Synchrony Financial director reported acquiring 660 restricted stock units of Synchrony Financial common stock as of December 31, 2025.
When do the newly granted Synchrony Financial restricted stock units vest?
The 660 restricted stock units will vest in full on December 31, 2026, according to the filing.
What does each restricted stock unit represent for Synchrony Financial (SYF)?
Each restricted stock unit represents a contingent right to receive one share of Synchrony Financial common stock upon vesting.
Was this Synchrony Financial insider transaction a stock sale or a grant?
The filing describes an equity grant of restricted stock units to a director, not an open-market purchase or sale.
What price is associated with the Synchrony Financial restricted stock unit grant?
The filing reports a price of $83.43 per share for the 660 restricted stock units acquired on December 31, 2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.